Eric Skaar Archives
Staph ‘gangs’ share nutrients during infection: study
Oct. 16, 2014—Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.
Faculty meeting highlights VUSM achievements
May. 29, 2014—Despite a challenging health care landscape, Vanderbilt University Medical Center continues to advance the highest-quality patient care, train the next generation of physician leaders and push forward the frontiers of biomedical science.
Anthrax bacteria’s signaling systems
Apr. 15, 2014—Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.
Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells
Mar. 3, 2014—Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.
Vanderbilt planning for the future
Jul. 5, 2013—An executive committee has been named and will meet regularly this summer to develop a framework of ideas to guide a university-wide academic strategic planning process that will set the course for Vanderbilt’s future.
Studies outline new model for staph bone infections
Jun. 20, 2013—Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus (“staph”) bacteria, is particularly challenging to treat.
Antibacterial protein’s molecular workings revealed
Feb. 21, 2013—Vanderbilt investigators report new insights to the workings of calprotectin, an immune system protein that “starves” bacterial pathogens of the metal nutrients they require.
Zinc: a new antibiotic target?
Jan. 17, 2013—It may be possible to fight hospital-acquired pathogens like Acinetobacter baumannii by targeting the bacterium’s need for the nutrient metal zinc.
Team creates new view of body’s infection response
Aug. 9, 2012—A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.